![Dean A. Falb](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Historial de carrera de Dean A. Falb
Antiguos cargos conocidos de Dean A. Falb.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
SYNLOGIC, INC. | Director Técnico/Científico/I+D | 01/10/2013 | 01/05/2018 |
STRYKER CORPORATION | Director Técnico/Científico/I+D | 01/01/2005 | 01/01/2012 |
LOGICBIO THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/05/2018 | - |
Praecis Pharmaceuticals, Inc.
![]() Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Praecis Pharmaceuticals, Inc. develops drugs and therapies for the treatment of cancer. The firm also develops peptide-based drugs. The company was founded 1993 and is headquartered in Waltham, MA. | Director Técnico/Científico/I+D | - | - |
Formación de Dean A. Falb.
Harvard University | Doctorate Degree |
Purdue University | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 7 |
Operativa
Chief Tech/Sci/R&D Officer | 4 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 5 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
SYNLOGIC, INC. | Health Technology |
STRYKER CORPORATION | Health Technology |
Empresas privadas | 2 |
---|---|
Praecis Pharmaceuticals, Inc.
![]() Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Praecis Pharmaceuticals, Inc. develops drugs and therapies for the treatment of cancer. The firm also develops peptide-based drugs. The company was founded 1993 and is headquartered in Waltham, MA. | Health Technology |
LogicBio Therapeutics, Inc.
![]() LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Dean A. Falb
- Experiencia